44 results
8-K/A
EX-99.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
9 Nov 23
Ligand Reports Third Quarter 2023 Financial Results
9:48pm
to the unpredictable nature of the pandemic and related Captisol sales, Ligand excludes Captisol sales related to COVID-19 from guidance and will update investors
8-K
EX-99.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
8 Nov 23
Ligand Reports Third Quarter 2023 Financial Results
4:08pm
to the unpredictable nature of the pandemic and related Captisol sales, Ligand excludes Captisol sales related to COVID-19 from guidance and will update investors
8-K
EX-99.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
8 Aug 23
Ligand Reports Second Quarter 2023 Financial Results
4:02pm
to the unpredictable nature of the pandemic and related Captisol sales, Ligand excludes Captisol sales related to COVID-19 from guidance and will update investors
8-K
EX-99.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
4 May 23
Ligand Reports First Quarter 2023 Financial Results
4:06pm
strategic growth plan and continue the development of its proprietary programs; the COVID-19 pandemic and any future epidemic diseases could adversely
8-K
EX-99.1
fye6jgsu
7 Nov 22
Ligand Reports Third Quarter 2022 Financial Results
4:04pm
8-K
EX-99.1
5azjah
8 Aug 22
Ligand Reports Second Quarter 2022 Financial Results
4:06pm
425
EX-99.1
eb4mw8
21 Jun 22
Business combination disclosure
8:00am
8-K
EX-99.1
i83tdluaqy di
21 Jun 22
Regulation FD Disclosure
6:19am
425
s1w61tf8d
5 May 22
Business combination disclosure
7:30am
8-K
EX-99.1
2ujysu
4 May 22
Ligand Reports First Quarter 2022 Financial Results
4:03pm
425
2cc5c61
24 Mar 22
Business combination disclosure
9:09am
8-K
mxnng3yac iz
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
425
s31jyvj0jgwc
23 Mar 22
Business combination disclosure
5:29pm
425
EX-99.2
ete8u2byipjdrqwz5ono
23 Mar 22
Business combination disclosure
5:29pm
425
EX-99.1
0v2j2yba8gv6 xed54aj
23 Mar 22
Business combination disclosure
5:29pm
8-K
0m0w66c66k5um78f0
23 Mar 22
Ligand to Spin-Off its OmniAb Business Through Merger with Avista Public Acquisition Corp. II
5:25pm